Decitabine (5-Aza-2'-deoxycytidine) decreased DNA methylation and expression of MDR-1 gene in K562/ADM cells

Leukemia

Volumn 14, Issue 11, 2000, Pages 1915-1920

  Ando, T ^a   Nishimura, M ^a   Oka, Y ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Decitabine; GC Box; MDR 1; Methylation

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BISULFITE; CYTOSINE; DNA; DNA METHYLTRANSFERASE; DOXORUBICIN; GLYCOPROTEIN P; GUANINE; ISOSORBIDE DINITRATE; METHYLTRANSFERASE INHIBITOR; MULTIDRUG RESISTANCE PROTEIN; OLIGONUCLEOTIDE; PROTEIN ANTIBODY; RNA; SODIUM HYDROXIDE; TRANSCRIPTION FACTOR;

ARTICLE; BINDING SITE; CELL STRAIN K 562; CONTROLLED STUDY; DEMETHYLATION; DNA METHYLATION; DNA SEQUENCE; DOWN REGULATION; ENHANCER REGION; FLOW CYTOMETRY; GENE CONTROL; GENE EXPRESSION REGULATION; GENE REPRESSION; GENETIC ANALYSIS; HEMATOLOGIC DISEASE; HUMAN; HUMAN CELL; LEUKEMIA; MULTIDRUG RESISTANCE; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS;

EID: 0033764141     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401914     Document Type: Article

References (26)

1. Genetic and biochemical characterization of multidrug resistance
2. The basis of multidrug resistance in mammalian cells: Homology with bacterial transport
3. Mechanisms of multidrug resistance and implications for therapy
4. Isolation and sequence of the promoter region of the human multidrug-resistance (P-glycoprotein) gene
5. SP1 activates the MDR1 promoter through one of two distinct G-rich regions that modulate promoter activity
6. 12-O-tetradecanoylphorbol-13-acetate activation of the MDR1 promoter is mediated by EGR1
7. DNA methylation and mutation
8. The essentials of DNA methylation
9. CpG-rich islands and the function of DNA methylation
10. High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines
11. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma
12. 5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers
13. Hypermethylation associated inactivation indicates a tumor suppressor role for p15INK4B
14. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas
15. Cytosine methylation changes during normal hematopoiesis and in acute myeloid leukemia
16. Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia
17. Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells
18. The effects of 5-azacytidine and 5-azadeoxycytidine on chromosome structure and function: Implications for methylation-associated cellular processes
19. Insights into X chromosome inactivation from studies of species variation, DNA methylation and replication, and vice versa
20. Role for DNA methylation in genomic imprinting
21. Methylation of the p15(INK4b) gene in myelodysplastic syndromes is frequent and acquired during disease progression
22. Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene
23. Cytosine methylation does not effect binding of transcription factor Sp1
24. Altered methylation of the human MDR-1 promoter is associated with acquired multidrug resistance
25. The mechanism of trans-activation of the MDR1 gene by human T cell leukemia virus
26. Methylation analysis of the human multidrug resistance 1 gene in normal and leukemic hematopoietic cells